November 2, 2016
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
Pharmaceuticals, Biotechnology and Life Sciences
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.